Specific T cell receptor targeting NY-ESO-1(157-165) epitope and anti-tumor application

A cell receptor and epitope technology, applied in the field of medicine, can solve the problem of uncertain prospects for CAR-T cell therapy, and achieve the effect of inhibiting tumor growth

Active Publication Date: 2020-09-22
英威福赛生物技术(天津)有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prospect of CAR-T cell therapy in the treatmen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0051] Example 1. Preparation of NY-ESO-1(157-165) polypeptide / HLA-A2 tetramer and antigen-specific T cell sorting and TCR gene cloning

[0052] In this example, by preparing NY-ESO-1(157-165) / HLA-A2 tetramer, staining mouse splenocytes after immunization with CD3 and CD8 antibodies, and sorting NY- ESO-1(157-165) specific T cells for subsequent TCR screening.

[0053] 1. Preparation of NY-ESO-1(157-165) / HLA-A2 tetramer

[0054] (1) Refolding and purification of NY-ESO-1(157-165) / HLA-A2 complex

[0055] Optimize β2m (β2-microglobulin, HLA-A2 light chain gene) (Uniprot: P61769) and HLA-A2 heavy chain gene (Uniprot: P01892) according to prokaryotic codons, and add Express the sequence of biotin-specific binding polypeptide (Biotin-tag), synthesize the DNA sequence respectively, and introduce the enzyme cutting sites Nde I and Xho I respectively, wherein the Nde I enzyme cutting site is located at the 5' end of the sequence, and the enzyme cutting site Point Xho I is loca

Example Embodiment

[0097] Example 2. NY-ESO-1(157-165) / HLA-A2 tetramer binding experiment with cells expressing YW-TCR-1 TCR

[0098] In order to further confirm that the screened YW-TCR-1 TCR can specifically recognize NY-ESO-1(157-165) / HLA-A2, in this example, the α chain and β chain variable regions of YW-TCR-1 TCR (V region) (ie, SEQ ID NO: 1 and SEQ ID NO: 2) gene and human TCR α chain and β chain constant region (C region) gene (synthesized by Hongxun Biological Co., Ltd.) to form YW-TCR-1 TCR ( That is, the gene of SEQ ID NO:9+SEQ ID NO:10) was connected to the pCDH-GFP lentiviral expression plasmid (System Biosciences: Cat. No.: CD527A-1), and the chimeric YW-TCR-1 TCR expression vector (YW-TCR-1 -pCDH). HEK-293T cells (purchased from ATCC) were co-transfected with YW-TCR-1-pCDH plasmid and CD3-CD8-pCDH plasmid expressing CD3 and CD8. After 24 hours of transfection, the cells were centrifuged; washed three times with PBS containing 0.5% BSA, and centrifuged; - CD3 was co-incubated wi

Example Embodiment

[0100] Example 3. Preparation of YW-TCR-1 TCR protein and determination of its affinity with NY-ESO-1(157-165) / HLA-A2

[0101] The researchers further determined the binding affinity between YW-TCR-1 TCR and NY-ESO-1(157-165) / HLA-A2 at the protein level.

[0102] 1. Preparation of YW-TCR-1 TCR protein

[0103] The extracellular region genes of YW-TCR-1 TCR α chain and β chain were optimized according to prokaryotic codons, and the DNA sequences of the extracellular regions of YW-TCR-1 TCR α chain and β chain were synthesized, respectively, and introduced into restriction enzymes Sites Nde I and Xho I, wherein the Nde I restriction site is located at the 5' end of the sequence, and the restriction site Xho I is located at the 3' end of the sequence. The DNA sequences of the extracellular regions of the synthesized YW-TCR-1 TCR α chain and β chain were cloned into the expression vector pET21 a (Invitrogen) by using restriction sites Nde I and Xho I to establish the YW-TCR-1 TC

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a specific T cell receptor targeting an NY-ESO-1 (157-165) epitope and anti-tumor application. The T cell receptor is composed of an alpha peptide chain and a beta peptide chain, and the invention also provides an antigen binding fragment of the T cell receptor, nucleic acid for encoding the T cell receptor and the antigen binding fragment thereof, a vector containing the nucleic acid, and a host cell containing the vector; the invention also provides a method for preparing the NY-ESO-1 specific T cell receptor or the antigen binding fragment thereof. The specific T cellreceptor and the antigen binding fragment thereof can be used as an immune effect activator to stimulate the immune response of an organism, thereby achieving an effect of resisting diseases such astumors.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 英威福赛生物技术(天津)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products